Skip to main content

Table 2 Clinical characteristics of patients with RRT during hospitalization

From: Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients

Cohort

TBSA (%)

LOS (days)

INH

Septicemia

First drug exposure (days)

RRT begin (days)

RRT duration (days)

CrBL (mg/dl)

CrΔ% (%)

KDIGO+

Survivors

 V/PT

62

105

N

N

1

6

76

0.8

365

Y

 V/PT

80

141

Y

Y

0

40

13

0.7

18

N

 V/PT

32

26

N

N

0

10

2

1.01

77

Y

Non-survivors

 V/IC

95

9

Y

Y

1

10

1

0.9

0

N

 V/PT

62

234

N

N

0

8

18

0.9

422

Y

 V/PT

45

15

N

Y

1

10

4

0.95

21

N

 V/PT

40

23

N

Y

0

19

3

0.9

30

N

  1. Cr BL baseline creatinine concentration, CrΔ% relative creatinine increase, IC imipenem-cilastin, INHpresence of inhalation injury at admission, LOS length of hospitalization (days), N no, PT piperacillin-tazobactam,KDIGO+ KDIGO stage 1,2, or 3 during 7 days following exposure, RRT renal replacementtherapy, TBSA total body surface area burned (%), V vancomycin, Y yes
Back to article page

Critical Care

ISSN: 1364-8535